| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
4,073 | 4,632 | 2,983 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-54,392 | -52,346 | -50,161 | -43,387 | -29,819 |
|
Research and Development Expenses
|
-146,201 | -160,636 | -155,289 | -147,905 | -86,725 |
|
Operating Income/Expenses
|
-200,593 | -212,982 | -205,450 | -191,292 | -116,544 |
|
Total Operating Profit/Loss
|
-196,520 | -208,350 | -202,467 | -191,292 | -116,544 |
| Total Net Finance Income/Expense
|
4,033 | 4,149 | 3,522 | 2,811 | -- |
|
Amortization and Accretion of Securities
|
2,403 | 2,479 | 3,507 | 5,677 | -- |
| Net Investment Income
|
1,993 | 432 | -485 | -2,382 | -8,128 |
| Irregular Income/Expenses
|
0 | -- | 0 | -13,500 | 0 |
|
Other Income/Expense, Non-Operating
|
199 | 148 | 41 | 274 | 1,903 |
|
Non-Operating Income/Expenses, Total
|
8,628 | 7,208 | 6,585 | -7,120 | -6,225 |
|
Pretax Income
|
-187,892 | -201,142 | -195,882 | -198,412 | -122,769 |
|
Provision for Income Tax
|
0 | -- | 0 | 279 | 948 |
|
Net Income from Continuing Operations
|
-187,892 | -201,142 | -195,882 | -198,133 | -121,821 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-187,892 | -201,142 | -195,882 | -198,133 | -121,821 |
|
Net Income after Non-Controlling/Minority Interests
|
-187,892 | -201,142 | -195,882 | -198,133 | -121,821 |
| Preferred/Other Stock Distribution
|
-- | -- | -- | 0 | -20,193 |
|
Other Adjustments to Net Income Available to Common Stockholders
|
-- | -- | -- | -- | 0 |
|
Net Income Available to Common Stockholders
|
-187,892 | -201,142 | -195,882 | -198,133 | -142,014 |
|
Diluted Net Income Available to Common Stockholders
|
-187,892 | -201,142 | -195,882 | -198,133 | -142,014 |
| Basic EPS
|
-1.07 | -1.35 | -1.65 | -2.18 | -4.19 |
| Diluted EPS
|
-1.07 | -1.35 | -1.65 | -2.18 | -4.19 |
|
Basic Weighted Average Shares Outstanding
|
173,119.3100 | 148,758.5270 | 118,600.3810 | 90,969.3270 | 33,891.2640 |
|
Diluted Weighted Average Shares Outstanding
|
173,119.3100 | 148,758.5270 | 118,600.3810 | 90,969.3270 | 33,891.2640 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-191,925 | -205,291 | -199,404 | -201,223 | -122,769 |
|
EBITDA
|
-184,527 | -197,970 | -193,276 | -196,570 | -120,545 |
|
Normalized EBITDA
|
-159,749 | -169,134 | -166,723 | -166,750 | -105,950 |
|
Normalized Income
|
-163,114 | -172,306 | -169,329 | -168,342.8200 | -107,328.1650 |
|
Total Unusual Items
|
24,778 | 28,836 | 26,553 | 29,820 | 14,595 |
12/31/2022 - 10/20/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade